Gary Stetz, II

Director at Hepion Pharmaceuticals.

Earliest Form D on file: Aug 2026

Filed Aug 5, 2026

Hepion Pharmaceuticals

Blood tests for early liver cancer detection

Biotech, Red Bank NJ

Named, Director.

$3.055M

sold of $3.055M offered

Network

At Hepion Pharmaceuticals

7 people

Gary Stetz
Together on 1 filing
Executive Officer, Director, signed as Interim Chief Executive Officer
Vincent LoPriore
Together on 1 filing
Executive Officer, Director
Chase LoPriore
Together on 1 filing
Director
Dania Fisher
Together on 1 filing
Director
Michael Purcell
Together on 1 filing
Director
Sireesh Appajosyula
Together on 1 filing
Director

1 more at Hepion Pharmaceuticals